Zenocutuzumab Shows Efficacy in Patients with Advanced NRG1 Fusion-positive Cancers By Ogkologos - February 19, 2025 796 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the eNRGy study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR Enhertu May Be Preferred Therapy for Some Metastatic Breast Cancers October 19, 2021 3rd Grader Writes Note for Teacher Battling Breast Cancer to Read... May 24, 2019 EMA Issues Direct Healthcare Professional Communications for Crizotinib-Related Vision Disorders in... June 24, 2022 Man Who Lost His Leg Teaches Martial Arts To Orphans Of... December 7, 2021 Load more HOT NEWS Addressing Cancer Disparities and New Research in Treating HPV-Positive Head and... ESMO Targeted Anticancer Therapies Congress 2024, 26-28 February, Paris, France Grief Anniversaries Sotorasib Shows Promising Activity and Acceptable Safety in Patients with Previously...
